Market Cap (In ILA)
106.28 Million
Revenue (In ILA)
-
Net Income (In ILA)
-28.52 Million
Avg. Volume
758.83 Thousand
- Currency
- ILA
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9.0-32.0
- PE
- -
- EPS
- -
- Beta Value
- 1.044
- ISIN
- IL0004850116
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Shai Meretzki Ph.D.
- Employee Count
- -
- Website
- https://bonus-bio.com
- Ipo Date
- 2002-08-12
- Details
- Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS, as well as other life-threatening acute inflammatory diseases. Its products in pipeline comprise bone augmentation in osteoporosis patients; novel nano-materials for drug delivery; vascularized bone grafts; and soft tissue grafts. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.
More Stocks
-
SBSI
-
ORIENTHOTOriental Hotels Limited
ORIENTHOT
-
4706
-
BHLB
-
HIPRHiper Global Ltd.
HIPR
-
PLL
-
7721TOKYO KEIKI INC.
7721
-
1709